Effects of oestrogen on cardiovascular events in postmenopausal women

被引：0

作者：

Herrington, DM ^{[1
]}

机构：

[1] Wake Forest Univ, Sch Med, Dept Internal Med Cardiol, Winston Salem, NC 27157 USA

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2001年 / 3卷 / 0M期

关键词：

cardiovascular disease; hormone replacement therapy; oestrogen. primary prevention; secondary prevention;

D O I：

10.1016/S1520-765X(01)90076-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A number of randomized clinical trials have investigated the role of hormone replacement therapy (HRT) in primary and secondary prevention of clinical and anatomical manifestations of atherosclerosis. There is mounting evidence that HRT does not slow the progression of clinical or anatomical manifestations of atherosclerosis in women with established disease. Indeed, there appears to be a pattern of increased risk among new users of HRT. In contrast, there are encouraging new data that suggest that HRT may be more effective in women who have not yet developed clinical manifestations of coronary disease. (C) 2001 The European Society of Cardiology.

引用

页码：M7 / M11

页数：5

共 50 条

[41] Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women
Villa, Paola
Suriano, Rosanna
Ricciardi, Luigi
Tagliaferri, Valeria
De Cicco, Simona
De Franciscis, Pasquale
Colacurci, Nicola
Lanzone, Antonio
FERTILITY AND STERILITY, 2011, 95 (01) : 158 - 163
[42] Pathways From Socioeconomic Factors to Major Cardiovascular Events Among Postmenopausal Veteran and Nonveteran Women: Findings From the Women's Health Initiative
Beydoun, Hind A.
Beydoun, May A.
Kinney, Rebecca L.
Liu, Simin
Yu, Rona
Allison, Matthew
Wallace, Robert B.
Xiao, Qian
Liu, Longjian
Gradidge, Philippe
Jung, Su Yon
Tindle, Hilary A.
Follis, Shawna
Brunner, Robert
Tsai, Jack
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (24):
[43] Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women
Bingol, Banu
Gunenc, Ziya
Yilmaz, Murat
Biri, Aydan
Tiras, Buelent
Guner, Haldun
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 281 (05) : 857 - 864
[44] The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women
Wren, Barry G.
MEDICAL JOURNAL OF AUSTRALIA, 2009, 190 (06) : 321 - 325
[45] HEALTH BELIEFS AND CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN IN IRAN
Abedi, Parvin
Hosseini, Mostafa
Shojaeezadeh, Davood
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2009, 25 (03) : 453 - 457
[46] Rise and fall of hormone therapy in postmenopausal women with cardiovascular disease
Maas, AHEM
van der Schouw, YT
Grobbee, DE
van der Graaf, Y
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (02): : 228 - 235
[47] Different tools for estimating cardiovascular risk in Brazilian postmenopausal women
Nahas, Eliana A. P.
Andrade, Aline M.
Jorge, Mayra C.
Orsatti, Claudio L.
Dias, Flavia B.
Nahas-Neto, Jorge
GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (10) : 921 - 925
[48] Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options
Anagnostis, Panagiotis
Karras, Spyridon
Lambrinoudaki, Irene
Stevenson, John C.
Goulis, Dimitrios G.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (12) : 967 - 977
[49] Risk Factors for Cardiovascular Events among Pregnant Women with Cardiovascular Disease
Nii, Masafumi
Tanaka, Hiroaki
Tanaka, Kayo
Katsuragi, Shinji
Kamiya, Chizuko A.
Shiina, Yumi
Niwa, Koichiro
Ikeda, Tomoaki
INTERNAL MEDICINE, 2020, 59 (09) : 1119 - 1124
[50] Hyperhomocysteinemia and cardiovascular risk in postmenopausal women:: the role of folate supplementation
Villa, Paola
Suriano, Rosanna
Costantini, Barbara
Macri, Francesca
Ricciardi, Luigi
Campagna, Giuseppe
Lanzone, Antonio
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (02) : 130 - 135

← 1 2 3 4 5 →